Apnimed director granted options on 169K shares

Apnimed, Inc. (APMD) reported the initial beneficial ownership of director Paul J. Sekhri.

Rhea-AI Filing Summary

Apnimed, Inc. (APMD) reported the initial beneficial ownership of director Paul J. Sekhri. He holds a stock option to purchase 169,468 shares of Class A Common Stock at an exercise price of $8.15 per share, expiring on May 28, 2036. One-third of the option vests after twelve months of continuous service following June 1, 2026, and the remaining shares vest in substantially equal quarterly installments over the next 24 months, subject to his continued service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider SEKHRI PAUL J

Role Director

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy) F1	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 169,468 contracts (Direct)

Footnotes (1)

1. F1. One-third of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 24 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

Key Figures

Underlying shares: 169,468 shares Exercise price: $8.15 per share Option expiration date: May 28, 2036 +2 more

5 metrics

Underlying shares 169,468 shares Shares of Class A Common Stock underlying reported stock option holding

Exercise price $8.15 per share Exercise price of Stock Option (Right to Buy) held by Paul J. Sekhri

Option expiration date May 28, 2036 Expiration date of the Stock Option (Right to Buy)

Vesting cliff period 12 months Initial period of continuous service after June 1, 2026 before one-third of option vests

Subsequent vesting period 24 months Remaining shares vest in substantially equal quarterly installments over this period

Key Terms

Stock Option (Right to Buy), Class A Common Stock, continuous service, quarterly installments

4 terms

Stock Option (Right to Buy) financial

"security_title is listed as Stock Option (Right to Buy)"

Class A Common Stock financial

"underlying_security_title is reported as Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

continuous service financial

"vest and become exercisable when the Reporting Person completes twelve months of continuous service"

quarterly installments financial

"remainder of the shares vest and become exercisable in substantially equal quarterly installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider position did Paul J. Sekhri report in Apnimed, Inc. (APMD)?

Paul J. Sekhri reported holding a stock option over 169,468 shares of Apnimed Class A Common Stock. The option has an exercise price of $8.15 per share and represents his initial beneficial ownership disclosure as a director.

What is the exercise price of Paul J. Sekhri’s stock option in APMD?

The exercise price of Paul J. Sekhri’s stock option is $8.15 per share. This price applies to the entire 169,468-share option position disclosed in his initial beneficial ownership report for Apnimed, Inc.

How many Apnimed (APMD) shares are covered by Paul J. Sekhri’s option?

Paul J. Sekhri’s stock option covers 169,468 underlying shares of Apnimed Class A Common Stock. These shares become exercisable over a three-year vesting schedule tied to his continuous service with the company.

When does Paul J. Sekhri’s Apnimed stock option vest?

One-third of the option shares vest after 12 months of continuous service following June 1, 2026. The remaining two-thirds vest in substantially equal quarterly installments over 24 months, contingent on continued service at each vesting date.

When does Paul J. Sekhri’s Apnimed (APMD) stock option expire?

Paul J. Sekhri’s stock option expires on May 28, 2036. He may exercise vested portions of the 169,468-share option at an exercise price of $8.15 per share any time before this expiration date, subject to plan terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 07:35 PM Accepted by SEC EDGAR 07/30/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

SEKHRI PAUL J

(Last) (First) (Middle)

APNIMED, INC.

39 JOHN F. KENNEDY STREET, 4TH FLOOR

(Street)

CAMBRIDGE MASSACHUSETTS 02138

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/30/2026

3. Issuer Name and Ticker or Trading Symbol
Apnimed, Inc. [ APMD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	05/28/2036	Class A Common Stock	169,468	$8.15	D

Explanation of Responses:

1. One-third of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 24 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

Remarks:

Exhibit 24 - Power of Attorney

	/s/Kevin R. Lind, Attorney-in-Fact	07/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)